Intramuscular administration of 15(S) 15 methyl prostaglandin E2 methyl ester for induction of abortion: a comparison of two dose schedules.
D000019:Abortifacient Agents / Q000008:administration & dosage*; D000028:Abortion, Induced / Q000009:adverse effects / Q000379:methods*; D000293:Adolescent; D000328:Adult; D000650:Amnion; D004716:Endometritis / Q000209:etiology; D004952:Esters; D005260:Female; D005334:Fever / Q000209:etiology; D006801:Humans; D007273:Injections, Intramuscular; D008745:Methylation; D010298:Parity; D011247:Pregnancy; D011312:Pressure; D011453:Prostaglandins / Q000008:administration & dosage* / Q000009:adverse effects / Q000633:toxicity; D013997:Time Factors; D014546:Urinary Catheterization; D014581:Urticaria / Q000139:chemically induced
D000019:Abortifacient Agents; D004952:Esters; D011453:Prostaglandins